An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Главный автор: | Bristy, Israt Zerin |
---|---|
Другие авторы: | Kabir, Md. Tanvir |
Формат: | Диссертация |
Язык: | English |
Опубликовано: |
Brac University
2021
|
Предметы: | |
Online-ссылка: | http://hdl.handle.net/10361/15619 |
Схожие документы
-
Molecules associated with the development of lung cancer
по: Rahman, Adree, и др.
Опубликовано: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
по: Shabnam, Musharrat
Опубликовано: (2018) -
Immunotherapy in the Management of Lung Cancer
по: Tasnim, Humayra
Опубликовано: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
по: Paul, Pulock
Опубликовано: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
по: Mim, Shanzida
Опубликовано: (2023)